---
title: PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation
date: '2024-08-31'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39216095/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&fc=20211015124055&ff=20240901181504&v=2.18.0.post9+e462414
source: N Engl J Med
description: 'CONCLUSIONS: Among patients with coronary artery disease who were undergoing
  TAVI, PCI was associated with a lower risk of a composite of death from any cause,
  myocardial infarction, or urgent revascularization at a median follow-up of 2 years
  than conservative treatment. (Funded by Boston Scientific and the Danish Heart Foundation;
  NOTION-3 ClinicalTrials.gov number, ...'
disable_comments: true
---
CONCLUSIONS: Among patients with coronary artery disease who were undergoing TAVI, PCI was associated with a lower risk of a composite of death from any cause, myocardial infarction, or urgent revascularization at a median follow-up of 2 years than conservative treatment. (Funded by Boston Scientific and the Danish Heart Foundation; NOTION-3 ClinicalTrials.gov number, ...